| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
346 |
| issn |
1176-6336 |
| issueIdentifier |
4 |
| pageRange |
337-346 |
| publicationName |
Therapeutics and Clinical Risk Management |
| startingPage |
337 |
| bibliographicCitation |
Cantor LB. Brimonidine in the treatment of glaucoma and ocular hypertension. Therapeutics and Clinical Risk Management. 2006 Dec;2(4):337–46. doi: 10.2147/tcrm.2006.2.4.337. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74ea92f4acf8b9d05c5eeead1dc4e4e3 |
| date |
200612 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC1936355
https://doi.org/10.2147/tcrm.2006.2.4.337
https://pubmed.ncbi.nlm.nih.gov/18360646 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1176-6336
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33049 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Brimonidine in the treatment of glaucoma and ocular hypertension |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8685
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7325
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7837
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638015
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7671
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8995 |